Efficiency of conservative therapy of inoperable esophageal cancer

The results of γ-beam therapy of esophageal cancer leave much to be desired. However betatron therapy improves then. To compare the results of esophageal cancer therapy 4 therapeutic modalities were employed: the 1st group-chemoradiotherapy (methotrexate at a weekly dose of 45 mg), the 2nd group - chemoradiography (methotrexate at a dose of 10 mg alternating with prospidine at a dose of 200 mg), the 3rd group - radiotherapy (inhibitory radiation), the 4th group - radiotherapy (γ-beam therapy). Higher efficacy of chemoradiotherapy as compared to radiotherapy only was established